EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles

Mae M Lewis iD, Melissa R Soto iD, Esther Y Maier iD, Steven D Wulfe iD, Sandy Bakheet iD, Hannah Obregon, Debadyuti Ghosh iD

Bioengineering & Translational Medicine · 2023-11 · 8 (6)

DOI: 10.1002/btm2.10580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 21.08.2023. Verfasst von Mae M Lewis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering The University of Texas at Austin Austin Texas USA. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although mRNA lipid nanoparticles (LNPs) are highly effective as vaccines, their efficacy for pulmonary delivery has not yet fully been established. A major barrier to this therapeutic goal is their instability during aerosolization for local delivery. This imparts a shear force that degrades the mRNA cargo and therefore reduces cell transfection. In addition to remaining stable upon aerosolization, mRNA LNPs must also possess the aerodynamic properties to achieve deposition in clinically relevant areas of the lungs. We addressed these challenges by formulating mRNA LNPs with SM‐102, the clinically approved ionizable lipid in the Spikevax COVID‐19 vaccine. Our lead candidate, B‐1, had the highest mRNA expression in both a physiologically relevant air–liquid interface (ALI) human lung cell model and in healthy mice lungs upon aerosolization. Further, B‐1 showed selective transfection in vivo of lung epithelial cells compared to immune cells and endothelial cells. These results show that the formulation can target therapeutically relevant cells in pulmonary diseases such as cystic fibrosis. Morphological studies of B‐1 revealed differences in the surface structure compared to LNPs with lower transfection efficiency. Importantly, the formulation maintained critical aerodynamic properties in simulated human airways upon next generation impaction. Finally, structure–function analysis of SM‐102 revealed that small changes in the number of carbons can improve upon mRNA delivery in ALI human lung cells. Overall, our study expands the application of SM‐102 and its analogs to aerosolized pulmonary delivery and identifies a potent lead candidate for future therapeutically active mRNA therapies.

Schlagwörter

Stichwörter der Autor:innen

aerosolizationionizable lipidlipid nanoparticlemRNApulmonary delivery

Autor:innen und Institutionen

  • Department of Biomedical Engineering The University of Texas at Austin Austin Texas USA.
  • Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy The University of Texas at Austin Austin Texas USA.
  • Drug Dynamics Institute The University of Texas at Austin Austin Texas USA.

ORCID-Profile: Mae M Lewis, Melissa R Soto, Esther Y Maier, Steven D Wulfe, Sandy Bakheet, Debadyuti Ghosh

Förderung

  • Cystic Fibrosis Foundation

Zitieren

APA

Lewis, M. M., Soto, M. R., Maier, E. Y., Wulfe, S. D., Bakheet, S., Obregon, H., & Ghosh, D. (2023). Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles. Bioengineering & Translational Medicine, 8(6). https://doi.org/10.1002/btm2.10580

Vancouver

Lewis MM, Soto MR, Maier EY, Wulfe SD, Bakheet S, Obregon H, et al. Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles. Bioengineering & Translational Medicine. 2023;8(6). doi:10.1002/btm2.10580

BibTeX
@article{Lewis2023,
  author = {Lewis, Mae M and Soto, Melissa R and Maier, Esther Y and Wulfe, Steven D and Bakheet, Sandy and Obregon, Hannah and Ghosh, Debadyuti},
  title = {Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles},
  journal = {Bioengineering & Translational Medicine},
  year = {2023},
  volume = {8},
  number = {6},
  doi = {10.1002/btm2.10580}
}
Kostenlos starten →